The widespread application of DNA microarrays to cancer research is nothing less than astounding. In the short ten-year history of this versatile technology, hundreds of large-scale experiments have ...

The alternative text for this image may have been generated using AI. The presence of chromosome-wide expression biases in data from three other laboratories as well as in 8% of our strains indicates ...

A new vaccine designed by AI is the first to be tested on humans and may protect against a wide range of coronaviruses ...

MtoZ Biolabs provides PhIP-Seq analysis support for antigen epitope screening, antibody repertoire profiling, autoantibody discovery, and biomarker research. BOSTON, MA, UNITED STATES, June 21, 2026 / ...

A coronavirus vaccine built to stay useful even as viruses change has cleared its first test in people, offering an early look at a strategy meant to get ahead of the next pandemic instead of ...

A new vaccine designed by AI is the first to be tested on humans and may protect against a wide range of coronaviruses ...

Discover how AI, automation, and next-generation DMTA workflows are accelerating drug discovery with expert insights from TTP ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the upcoming clinical availability of xH, a next-generation sequencing ...

Explore how researchers are using next-generation CRISPR therapies to target the root cause of muscle degeneration.

Terrestrial Bio today shared new preclinical data demonstrating the translatability of its patch technology for delivering ...

Introduction Sjögren’s disease (SjD) is a systemic, rheumatic autoimmune disorder evidenced by broad organ-specific ...

The biggest names in diabetes tech gathered last weekend for the American Diabetes Association’s 86th Scientific Sessions ...